Report Scope: The current report provides detailed exposure to the in vitro diagnostic analyzer market.This report highlights the current and future market potential of in vitro diagnostic analyzers along with a detailed analysis of the drivers, challenges and opportunities in the market.
The report also covers market projections to 2026 and market rank for key market players.It covers the competitive environment, patent analysis and regulatory scenario.
The report details the market shares of IVD analyzers based on test type, automation, design, application and end-user.The market is segmented into immunoassay analyzers, clinical chemistry, hematology and hemostasis analyzers, molecular diagnostic analyzers, POC analyzers and others based on test type.
By automation, analyzers are categorized into semi-automated and fully automated analyzers. Applications are infectious disease, diabetes, oncology, cardiology, nephrology and others. The market is segmented into hospitals, diagnostic centers, pharmaceutical companies, contract research organizations and academic research institutes, by end users. This report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report also describes the impact of the COVID-19 pandemic on this market.
By geographical region, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World regions. The North American region includes countries such as the U.S., Canada and Mexico, Europe includes Germany, the U.K., Italy and the Rest of Europe region, Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific region. For market estimates, data has been provided for 2019 as the historic year, 2020 as the base year and a forecast for 2026. The report does not cover the applications in other industries such as the veterinary and food industries.
Report Includes: - 27 data tables and 22 additional tables - An overview of the global market for In Vitro Diagnostics (IVD) analyzers - Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026 - Characterization and quantification of market potential for In Vitro Diagnostics (IVD) analyzers by region, type, automation, application, therapeutic area and end user - Information on new detection technologies and description of technological advances in fluidics for POC testing - Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry - Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and market forecast - Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis - Company profiles of major players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Quidel Corp., Roche and Siemens Healthineers AG
Summary: The global market for IVD analyzerswas valued at REDACTED in 2021.The market is forecast to grow at a compound annualgrowth rate (CAGR) of REDACTED to reach approximately REDACTED through 2026.
In this report, the global market is segmented by test type, automation, application, end user and region.
Reasons for Doing This Study: In vitro diagnostic tests performed on biological samples (blood, urine, saliva, spinal fluid and DNA) diagnose various diseases or assess health conditions. The information provided by IVD tests enable decision making for health care providers.
Due to recent rapid technological advancements and automation, the range and complexity of diagnostic tests have increased significantly.Disease detection is now possible before the appearance of symptoms, predicting beneficial and adverse treatment outcomes.
The growing focus on point-of-care (POC) diagnostics leads to the development of compact and portable analyzers. As more IVD tests become compatible with POC environments, healthcare providers may take advantage of evolving IVDs to effectively treat life-threatening illness, optimizing healthcare delivery.
This report will provide a detailed analysis of key factors governing the growth of the IVD analyzers industry, providing strategic insights and recommendations for those looking to expand.
Our reports have been used by over 10K customers, including:
Diagnostics are central to healthcare, but not accessible to all.A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective...
683 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testing encompasses the sample-in-answer-out approach of diagnostic testing that generates results in minutes or...
Report Scope: The current report provides detailed information regarding the in vitro diagnostics quality controls market.This report highlights the current and future market potential of in vitro diagnostics controls and a detailed analysis of the drivers and challenges in the market. The report also covers market...
The IVD raw materials market by revenue is expected to grow at a CAGR of 5.86% during 2022-2027. The following factors are likely to contribute to the growth of the IVD raw materials market during the forecast period: • Increasing Prevalence of Infectious & Chronic Diseases • Growing Awareness for Early Diagnosis and Disease...
In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Test Location (PoC, Homecare), By End-use (Hospitals, Laboratory), By Application, By Technology, And Segment Forecasts, 2022 - 2030 In Vitro Diagnostic Market Growth & Trends The global in...
250 pages •
By The Business Research Company
• May 2022
Major companies in the in-vitro diagnostics devices and equipment market include Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc, and Thermo Fisher Scientific Inc. The global in-vitro diagnostics market is expected to grow from $83.64 billion in 2021 to $96.49 billion in 2022 at...
The Global Molecular Quality Controls Market size is expected to reach $259.4 million by 2028, rising at a market growth of 6.6% CAGR during the forecast period. Molecular quality controls are used to assess the performance of molecular tests like leukocyte reduced apheresis platelet (LRAP) units, virus load assays, pathogen detection,...
The Global In Vitro Diagnostics Partnering Terms and Agreements 2010-2022 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This...
miRNA Tools and Services Market By Product and Services (Research Tools, Services), By Technology (Extraction Tools, qRT-PCR, NGS, Microarray, Functional Analysis Tools, Others), By End User (Research and Academic Institutes, IVD, Pharma and Biotech Companies, CROs): Global Opportunity Analysis and Industry Forecast, 2021-2031 The...
In Vitro Diagnostics
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.